Genomic Sequencing and Identifying Driver Mutations in AML and MDS | OncLive
Genomic Sequencing and Identifying Driver Mutations in AML and MDS | OncLive
Jan 25, 2020
onclive.com
Treatment Options for AML Patients with IDH2, RUNX1, or DNMT3A Mutations | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Treatment Options for AML Patients with IDH2, RUNX1, or DNMT3A Mutations | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Aug 8, 2022
targetedonc.com
FLT3 Mutations’ Impact on Prognosis and Treatment in AML
6:43
FLT3 Mutations’ Impact on Prognosis and Treatment in AML
4.4K viewsOct 11, 2018
YouTubeOncLive
Treating AML
Treating AML
5 months ago
youandaml.com
Secondary-type mutations do not impact the favorable prognosis in NPM1-mutated AML
2:19
Secondary-type mutations do not impact the favorable prognosis in NPM1-mutated AML
350 viewsFeb 21, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
NPM1 mutations in AML: What are they, and how do they influence the treatment of AML?
5:00
NPM1 mutations in AML: What are they, and how do they influence the treatment of AML?
370 views9 months ago
YouTubeKnow AML
NPM1 mutations in AML: What are they, and how do they influence the treatment of AML?
1:54
NPM1 mutations in AML: What are they, and how do they influence the treatment of AML?
660 views9 months ago
YouTubeKnow AML
1:33
The current guidelines and therapies for TP53-mutated MDS and AML
1.6K viewsJun 26, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
5:45
Pathogenic TP53 Mutations Associated With Poor Prognosis in Pediatric AML
826 viewsDec 15, 2022
YouTubeCheckRare
47:56
AML diagnosis and treatment 2022
18.5K viewsDec 8, 2021
YouTubeStanley Kim
51:09
Understanding FLT3 in AML: What It Means and How It’s Treated
673 views11 months ago
YouTubeHealthTree Foundation for Leukemia
0:11
Acute myeloid leukemia, or #AML for short, is an aggressive type of blood cancer in which the bone marrow makes unhealthy blood cells. There are different subtypes of AML that are each caused by a unique mutation (or change) in the body’s genes. | Astellas Pharma US
113.8K viewsFeb 24, 2021
FacebookAstellas Pharma US
1:37
Dr. Hamilton on Prognostic Impact of Molecular Mutations in AML and MDS on HCT Outcomes
112 viewsJan 29, 2016
YouTubeOncLive
1:19
Webinar | FLT3 mutations in AML: Types, prevalence, and clinical significance
116 views3 months ago
YouTubeAML Hub
1:52
The role of MRD monitoring in the management of FLT3-mutated AML
73 views9 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:13
Acute myeloid leukemia: Genetic changes
1.4K viewsAug 26, 2021
YouTubeKnow AML
1:17
What is the prognosis for acute myeloid leukemia (AML)?
21.6K viewsNov 27, 2019
YouTubeYou and AML
16:18
Symposium | FLT3 mutations in AML: Types, prevalence, and clinical significance
270 views4 months ago
YouTubeAML Hub
4:51
The impact of IDH mutated clones in NPM1+ AML
583 viewsDec 13, 2021
YouTubeVJHemOnc – Video Journal of Hematology & H…
5:17
“How I treat” a patient with DNMT3A-mutated AML in remission post intensive chemotherapy
379 viewsAug 8, 2024
YouTubeAML Hub
0:13
The IDHNow for AML Sponsored Testing Program
57 views8 months ago
YouTubeNeoGenomics
5:16
An analysis of TP53 mutation in AML and HR-MDS
727 viewsJan 27, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
0:56
Dr. Betty Hamilton on Molecular Mutations in AML and MDS
84 viewsDec 30, 2015
YouTubeTargeted Oncology
2:15
Treatment strategies for patients with AML who possess a FLT3 mutation
274 viewsDec 12, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
5:38
Understanding AML-MRC and tAML
10K viewsNov 27, 2019
YouTubeYou and AML
4:16
Characteristics and outcomes of patients with AML and FLT3-TKD mutations
424 viewsJan 29, 2025
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:26
Dissecting the heterogeneity within AML with myelodysplasia-related gene mutations
50 viewsApr 3, 2025
YouTubeVJHemOnc – Video Journal of Hematology & H…
3:32
How Protein Modifications Drive Drug Resistance in AML – Dr. Theodoros Karantanos
1 month ago
YouTubeMD Newsline
0:44
Predictors of poor response to azacitidine, venetoclax, and magrolimab in TP53-mutated AML
296 viewsFeb 2, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
3:00
The classification of AML and the role of genetic biomarkers in the management of AML
536 viewsApr 5, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
See more